14
Participants
Start Date
October 31, 1999
Primary Completion Date
September 30, 2001
Study Completion Date
September 30, 2001
Trastuzumab
Lourdes Regional Cancer Center, Binghamton
Fox Chase Cancer Center, Philadelphia
Hematology/Oncology Associates, Port Saint Lucie
Washington University Barnard Cancer Center, St Louis
Yale-New Haven Hospital, New Haven
Massachusetts General Hospital Cancer Center, Boston
Dana-Farber Cancer Institute, Boston
Cape Cod Health Care, Hyannis
Nantucket Cottage Hospital, Nantucket
University of Texas - MD Anderson Cancer Center, Houston
Collaborators (1)
National Cancer Institute (NCI)
NIH
Genentech, Inc.
INDUSTRY
Dana-Farber Cancer Institute
OTHER